2024 IDC MarketScape for Worldwide Life Science R&D DCT Solutions and Consulting Services
Medidata is a Leader in Life Science R&D DCT Solutions and Consulting
Read an excerpt of the IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment report to learn why Medidata has been recognized as a leader.
IDC MarketScape Noted:
- “Consider Medidata when seeking an innovative technology partner with a portfolio of solutions and strong clinical domain expertise on DCT implementation strategy to accelerate recruitment and drive patient engagement.”
- “Medidata’s DCT Program is a scalable, flexible, and comprehensive technology solution, with the ability to virtualize as much or as little of a clinical trial as needed, including patient participation, data capture and management, monitoring and analysis, and supply dispensation.”
Source: “IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment”, by: Nimita Limaye, November 2024, IDC # US52713224
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. The Capabilities score measures vendor product, go-to-market and business execution in the short-term. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles.